Emily J. Johnson

538 total citations
10 papers, 398 citations indexed

About

Emily J. Johnson is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Emily J. Johnson has authored 10 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Nephrology. Recurrent topics in Emily J. Johnson's work include Diabetes Treatment and Management (2 papers), Cardiovascular Function and Risk Factors (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). Emily J. Johnson is often cited by papers focused on Diabetes Treatment and Management (2 papers), Cardiovascular Function and Risk Factors (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). Emily J. Johnson collaborates with scholars based in United States, Switzerland and United Arab Emirates. Emily J. Johnson's co-authors include Katherine R. Tuttle, Radica Z. Alicic, Brad P. Dieter, Joshua J. Neumiller, Susan A. Marsh, Mary F. Paine, Kathleen Köck, Yvonne S. Lin, Robert Hong and Seilesh C. Babu and has published in prestigious journals such as Diabetes, The FASEB Journal and Life Sciences.

In The Last Decade

Emily J. Johnson

10 papers receiving 395 citations

Peers

Emily J. Johnson
Simon Gross Australia
Ruhan Jia China
Uwe Hehnke Germany
Gema Marín‐Royo Spain
Yoshikazu Muroya Japan
Adeel Ijaz United States
Allison B. Lehtinen United States
Yu Ning Liu China
Anindya Ghosh Canada
Renfei Luo China
Simon Gross Australia
Emily J. Johnson
Citations per year, relative to Emily J. Johnson Emily J. Johnson (= 1×) peers Simon Gross

Countries citing papers authored by Emily J. Johnson

Since Specialization
Citations

This map shows the geographic impact of Emily J. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily J. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily J. Johnson more than expected).

Fields of papers citing papers by Emily J. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily J. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily J. Johnson. The network helps show where Emily J. Johnson may publish in the future.

Co-authorship network of co-authors of Emily J. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Emily J. Johnson. A scholar is included among the top collaborators of Emily J. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily J. Johnson. Emily J. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Alicic, Radica Z., Joshua J. Neumiller, Emily J. Johnson, Brad P. Dieter, & Katherine R. Tuttle. (2019). Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes. 68(2). 248–257. 93 indexed citations
4.
Alicic, Radica Z., Emily J. Johnson, & Katherine R. Tuttle. (2018). Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease. Advances in Chronic Kidney Disease. 25(2). 181–191. 116 indexed citations
5.
Alicic, Radica Z., Emily J. Johnson, & Katherine R. Tuttle. (2018). SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review. American Journal of Kidney Diseases. 72(2). 267–277. 104 indexed citations
6.
Johnson, Emily J., Dandan Tian, Yvonne S. Lin, et al.. (2018). Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product–Drug Interactions: A NaPDI Center Recommended Approach. Drug Metabolism and Disposition. 46(7). 1046–1052. 20 indexed citations
7.
8.
Johnson, Emily J. & Susan A. Marsh. (2016). Anti‐diabetic effects of class 1 histone deacetylase inhibition in a rodent model of type 2 diabetes mellitus. The FASEB Journal. 30(S1). 4 indexed citations
9.
Johnson, Emily J., et al.. (2016). Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice. Biopharmaceutics & Drug Disposition. 38(3). 251–259. 15 indexed citations
10.
Johnson, Emily J., Brad P. Dieter, & Susan A. Marsh. (2015). Evidence for distinct effects of exercise in different cardiac hypertrophic disorders. Life Sciences. 123. 100–106. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Gross Breakdown of academic impact, for papers by Ruhan Jia Breakdown of academic impact, for papers by Uwe Hehnke Breakdown of academic impact, for papers by Gema Marín‐Royo Breakdown of academic impact, for papers by Yoshikazu Muroya Breakdown of academic impact, for papers by Adeel Ijaz Breakdown of academic impact, for papers by Allison B. Lehtinen Breakdown of academic impact, for papers by Yu Ning Liu Breakdown of academic impact, for papers by Anindya Ghosh Breakdown of academic impact, for papers by Renfei Luo
Rankless by CCL
2026